Download this file

# pmid doi year title Hugo_Symbol
1 33297669 10.3324/haematol.2020.267294 2022 Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. BRAF
2 34710243 10.1002/ajh.26390 2022 Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. BRAF
3 34802044 10.1038/s41379-021-00954-z 2022 A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform. BRAF
4 34952945 10.1038/s41379-021-01002-6 2022 Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. BRAF
5 35064935 10.1111/his.14619 2022 Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. BRAF
6 35205796 10.3390/cancers14041050 2022 Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders. BRAF
7 35234079 10.1177/10668969221081432 2022 Hairy Cell Leukemia-Japanese Variant: Report of a Patient and Literature Review. BRAF
8 35356636 10.14740/jh942 2022 Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma. BRAF
9 35359040 10.3760/cma.j.cn112151-20211220-00915 2022 [Clinicopathological features and BRAF V600E and MYD88 L265P mutation status of nodal marginal zone lymphoma]. BRAF
10 35363510 10.1200/JCO.21.02840 2022 Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. BRAF
11 35437610 10.1007/s00277-022-04795-x 2022 Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant. BRAF
12 35450208 10.1177/20406207221090886 2022 Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib. BRAF
13 35454811 10.3390/cancers14081904 2022 Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. BRAF
14 35789115 10.1111/his.14718 2022 Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia. BRAF
15 36051021 10.1002/jha2.486 2022 Lymphoma-associated acquired von Willebrand syndrome responsive to splenectomy: A case report. BRAF
16 32273478 10.3324/haematol.2020.251579 2021 Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. BRAF
17 32638211 10.1007/s12020-020-02411-4 2021 Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study. BRAF
18 32929178 10.1038/s41379-020-00673-x 2021 The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. BRAF
19 32970929 10.1111/ajco.13449 2021 Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance. BRAF
20 33360690 10.1016/j.jss.2020.11.012 2021 Thyroid Cancer Identified After Positron Emission Tomography (PET) Shows Aggressive Histopathology. BRAF
21 33506327 10.1007/s00428-021-03032-6 2021 Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases. BRAF
22 33676171 10.1016/j.anndiagpath.2021.151720 2021 From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature. BRAF
23 33685720 10.1016/j.pathol.2021.01.002 2021 New developments in non-Hodgkin lymphoid malignancies. BRAF
24 33706747 10.1186/s12887-021-02590-7 2021 Giant congenital nodular melanoma in a newborn: a case report and literature review. BRAF
25 33735913 10.1182/blood.2020010137 2021 A rapid genotyping panel for detection of primary central nervous system lymphoma. BRAF
26 33777766 10.3389/fonc.2021.620435 2021 Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. BRAF
27 33895683 10.1016/j.ejca.2021.03.026 2021 Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer: A retrospective analysis of 47 cases. BRAF
28 33939500 10.1177/10668969211013402 2021 A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor. BRAF
29 34198843 10.3390/ijms22116099 2021 Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy. BRAF
30 34466010 10.2147/CCID.S323865 2021 Reactive Langerhans Cell Proliferation Mimicking Langerhans Cell Histiocytosis in Association with Sézary Syndrome: A Case Report and Literature Review. BRAF
31 34570179 10.1182/bloodadvances.2021004668 2021 Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. BRAF
32 31439678 10.3324/haematol.2019.230375 2020 Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. BRAF
33 31924734 10.1158/1078-0432.CCR-19-3443 2020 Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131). BRAF
34 32012328 10.1002/hon.2718 2020 High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. BRAF
35 32040482 10.1371/journal.pone.0227586 2020 Expression of the muscle-associated gene MYF6 in hairy cell leukemia. BRAF
36 32052529 10.1111/pin.12909 2020 Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma. BRAF
37 32458259 10.1007/s11033-020-05509-0 2020 BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system. BRAF
38 32627042 10.3892/or.2020.7612 2020 Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells. BRAF
39 32764384 10.3390/cancers12082182 2020 Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma. BRAF
40 33053749 10.3390/cancers12102936 2020 The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells. BRAF
41 33162442 10.11406/rinketsu.61.1469 2020 [Marginal zone lymphoma-like primary bone marrow lymphoma with long-term pancytopenia preceding diagnosis]. BRAF
42 33297339 10.3390/nu12123755 2020 Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells. BRAF
43 33330555 10.3389/fmed.2020.594118 2020 Sarcoidosis and Cancer: A Complex Relationship. BRAF
44 30320628 10.1097/PAS.0000000000001174 2019 An Immune Suppression-associated EBV-positive Anaplastic Large Cell Lymphoma With a BRAF V600E Mutation. BRAF
45 30586141 10.1001/jamadermatol.2018.3662 2019 Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma. BRAF
46 30611946 10.1016/j.wneu.2018.12.128 2019 The Radiological Imaging Features of Easily Misdiagnosed Epithelioid Glioblastoma in Seven Patients. BRAF
47 30623224 10.1007/s00347-018-0840-8 2019 [New molecular pathological strategies for malignant iris tumors]. BRAF
48 30653166 10.1097/MD.0000000000014180 2019 Simultaneous Hodgkin lymphoma and BRAFV600E-positive papillary thyroid carcinoma: A case report. BRAF
49 30869573 10.1089/thy.2018.0511 2019 Combination Treatment with the BRAF<sup>V600E</sup> Inhibitor Vemurafenib and the BH3 Mimetic Navitoclax for BRAF-Mutant Thyroid Carcinoma. BRAF
50 30937513 10.1007/s00292-019-0586-3 2019 [Bronchoalveolar lavage in hairy cell leukemia with pulmonary infiltration]. BRAF
51 31172191 10.1093/ajcp/aqz056 2019 Histiocytic Sarcoma Following B-Lymphoblastic Leukemia/Lymphoma. BRAF
52 31257073 10.1016/j.ccell.2019.05.015 2019 RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance. BRAF
53 31281144 10.11406/rinketsu.60.559 2019 [Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration]. BRAF
54 31317311 10.1007/s00428-019-02608-7 2019 Clonal evolution of chronic lymphocytic leukemia to Langerhans cell histiocytosis: a case report. BRAF
55 31354304 10.2147/OTT.S202061 2019 <i>BRAF</i> V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia. BRAF
56 31443309 10.3390/medicina55080490 2019 Malignant Pleural Effusion and Its Current Management: A Review. BRAF
57 31447330 10.1016/j.lpm.2019.07.026 2019 [Hairy cell leukemia]. BRAF
58 31538423 10.3349/ymj.2019.60.10.890 2019 Hairiness is a Facsimile of Reorganized Cytoskeletons: A Cytopathic Effect of <i>Coxiella burnetii</i>. BRAF
59 31591741 10.1002/ajh.25653 2019 Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. BRAF
60 29439113 10.1136/gutjnl-2016-312608 2018 Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. BRAF
61 29556019 10.1038/s41375-018-0082-4 2018 High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations. BRAF
62 29565494 10.26355/eurrev_201803_14479 2018 Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion. BRAF
63 29618685 10.11406/rinketsu.59.281 2018 [Splenic diffuse red pulp small B-cell lymphoma diagnosed by splenectomy initially mimicking hairy cell leukemia-Japanese variant]. BRAF
64 29702524 10.1097/MOH.0000000000000435 2018 Genetic convergence of rare lymphomas. BRAF
65 29708356 10.14735/amko2018130 2018 MAPK/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis. BRAF
66 29846633 10.1210/jc.2017-01845 2018 Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts. BRAF
67 29854308 10.18632/oncotarget.25209 2018 Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel. BRAF
68 29857068 10.1016/j.jid.2018.04.038 2018 Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. BRAF
69 29895903 10.1038/s41408-018-0089-0 2018 Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. BRAF
70 29989027 10.18632/oncotarget.25601 2018 New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. BRAF
71 30035752 10.1097/DAD.0000000000001072 2018 Langerhans Cell Histiocytosis Associated With Underlying Hematolymphoid Disorders in Adults: Report of 2 Cases and Review of the Literature. BRAF
72 30335863 10.1371/journal.pone.0206014 2018 Oncogenic mutations in IKKβ function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation. BRAF
73 30474563 10.1186/s13000-018-0772-2 2018 Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature. BRAF
74 26882062 10.1097/IOP.0000000000000661 2017 Comparative Study of Clinical, Pathological, Radiological, and Genetic Features of Patients With Adult Ocular Adnexal Xanthogranulomatous Disease, Erdheim-Chester Disease, and IgG4-Related Disease of the Orbit/Ocular Adnexa. BRAF
75 27347751 10.1080/10428194.2016.1196813 2017 Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies. BRAF
76 27910030 10.1007/978-1-4939-6703-2_22 2017 Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. BRAF
77 28084334 10.1038/modpathol.2016.235 2017 Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. BRAF
78 28246485 10.3748/wjg.v23.i6.1106 2017 Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin. BRAF
79 28280620 10.21037/jgo.2017.01.14 2017 Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis. BRAF
80 28297625 10.1200/JCO.2016.71.1556 2017 Genomics of Hairy Cell Leukemia. BRAF
81 28376906 10.1186/s13256-017-1253-z 2017 BRAF <sup>V600E</sup> expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case report. BRAF
82 28399347 10.22608/APO.201710 2017 Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes--The 2017 J. Donald M. Gass Lecture. BRAF
83 28592763 10.11406/rinketsu.58.480 2017 Malignant lymphoma: pathophysiology and current therapy. BRAF
84 28880462 10.1111/cup.13017 2017 Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature. BRAF
85 28883003 10.1158/0008-5472.CAN-16-2691 2017 Discovery of Human-Similar Gene Fusions in Canine Cancers. BRAF
86 28892161 10.1002/path.4982 2017 A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors. BRAF
87 28976960 10.1038/nature24037 2017 Cancer drug addiction is relayed by an ERK2-dependent phenotype switch. BRAF
88 29110361 10.1002/ajh.24936 2017 Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment. BRAF
89 26426381 10.1097/PAS.0000000000000523 2016 NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease. BRAF
90 26800678 10.1007/s00108-015-0006-6 2016 [Classification of malignant lymphomas. Current situation]. BRAF
91 26868143 10.1007/s00428-015-1881-x 2016 CD27-positive hairy cell leukemia-Japanese variant. BRAF
92 26941398 10.1182/blood-2015-11-680074 2016 BRAF inhibition in hairy cell leukemia with low-dose vemurafenib. BRAF
93 27034005 10.18632/oncotarget.8427 2016 Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. BRAF
94 27121112 10.3109/10428194.2016.1173212 2016 Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. BRAF
95 27135738 10.1038/nm.4092 2016 An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. BRAF
96 27149123 NA 2016 Flavopiridol Induces Apoptosis via Mitochondrial Pathway in B16F10 Murine Melanoma Cells and a Subcutaneous Melanoma Tumor Model. BRAF
97 27275640 NA 2016 [Novelties in the diagnostics and therapy of hairy cell leukemia]. BRAF
98 27600764 10.1038/ncomms12602 2016 Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. BRAF
99 27672108 10.1093/annonc/mdw282 2016 First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas. BRAF
100 27889782 10.1159/000453085 2016 Molecular Pathology: A Requirement for Precision Medicine in Cancer. BRAF